BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 7402798)

  • 1. Bioavailability and pharmacokinetics of theophylline following plain uncoated and sustained-release dosage forms in relation to smoking habit. II. Multiple dose study.
    Ishizaki T; Horai Y; Sasaki T; Chiba K; Ohnishi A; Suganuma T; Tsujimoto G; Echizen H; Okaniwa T
    Eur J Clin Pharmacol; 1983; 24(3):361-9. PubMed ID: 6861849
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
    Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
    Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
    Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
    Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of diurnal changes in the disposition of theophylline.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Oct; 16(4):413-6. PubMed ID: 6684947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once a day theophylline; serum concentrations.
    Nerminathan V; McKenzie SA
    Arch Dis Child; 1984 Aug; 59(8):762-5. PubMed ID: 6476876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
    Hendeles L; Iafrate RP; Weinberger M
    Clin Pharmacokinet; 1984; 9(2):95-135. PubMed ID: 6370542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise and fall of serum theophylline concentration: a comparison of sustained-release formulations in volunteers with rapid theophylline clearance.
    Mucklow JC; Kuhn S
    Br J Clin Pharmacol; 1985 Dec; 20(6):589-96. PubMed ID: 4091990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and a sustained release theophylline tablet on chronic dosing: bioavailability, peak-trough and trough-trough differences.
    Lagas M; Jonkman JH
    Pharm Weekbl Sci; 1985 Feb; 7(1):10-4. PubMed ID: 3982951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food induced changes in theophylline absorption from a once-a-day theophylline product.
    Steffensen G; Pedersen S
    Br J Clin Pharmacol; 1986 Nov; 22(5):571-7. PubMed ID: 3790404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spiramycin has no effect on serum theophylline in asthmatic patients.
    Debruyne D; Jehan A; Bigot MC; Lechevalier B; Prevost JN; Moulin M
    Eur J Clin Pharmacol; 1986; 30(4):505-7. PubMed ID: 3743628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with theophylline for the management of chronic asthma.
    Weinberger M; Hendeles L
    Eur J Respir Dis Suppl; 1980; 109():120-33. PubMed ID: 6777183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline for chronic asthma: rationale for treatment, product selection, and dosage schedule.
    Weinberger M; Hendeles L
    Pediatr Pharmacol (New York); 1983; 3(3-4):273-85. PubMed ID: 6429620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a 12-hour sustained-release preparation in maintaining therapeutic serum theophylline levels in asthmatic children.
    Kelly HW; Murphy S
    Pediatrics; 1980 Jul; 66(1):97-102. PubMed ID: 7402798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
    Kelly HW; Murphy S
    Am J Hosp Pharm; 1979 Dec; 36(12):1698-701. PubMed ID: 525646
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.